The results of numerous epidemiological and bioinformatic studies convincingly show the connection of the STON1 gene (its expression) with BC (on a model of BC-specific cell lines (MCF-7)) [97,98,99] as well as the same with other various oncological diseases: pancreatic duct adenocarcinoma [100], lung cancer [101,102,103], colorectal cancer [104,105,106], papillary renal cell carcinoma [107], colon carcinoma (liver metastases) [108], basal cell skin cancer [109], clear cell kidney carcinoma [96], bladder carcinoma [110,111], and glioma [112], including in the GWAS data (lung cancer [103]). This evidence concerns the gene STON1 and urinary bladder carcinoma.